Indian equities posted their steepest weekly fall in seven months as the Sensex and Nifty extended losses amid U.S. visa curbs and drug tariffs. Pharma and IT stocks dragged, while FIIs stayed cautious. Analysts flagged key support at 24,500, with volatility expected around monthly expiry and global uncertainties weighing on sentiment.
New investor additions in markets declined by 11.6% in November (MoM): NSE Report
The pace of new investor additions in the equity markets slowed in November, with growth declining 11.6 per cent month-on-month, as only 13.2 lakh new